SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-033738
Filing Date
2018-06-11
Accepted
2018-06-11 16:05:34
Documents
1
Period of Report
2018-06-11

Document Format Files

Seq Description Document Type Size
1 6-K tv496264_6k.htm 6-K 10367
  Complete submission text file 0001144204-18-033738.txt   11565
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 18892028
SIC: 2834 Pharmaceutical Preparations